Table 1 Patient characteristics
Characteristic | N |
|---|---|
Sex | |
Male | 17 |
Female | 15 |
Age, years | |
Median | 51 |
Range | 23–72 |
ECOG performance status | |
0 | 26 |
1 | 5 |
2 | 1 |
Number of involved sites | |
0 | 1 |
1 (sc/ln) | 6 (4/2) |
2 | 9 |
>2 | 16 |
Tumor site | |
M0 | 1 |
Skin, sc, ln | 11 |
Lung | 2 |
Other visceral/(CNS) | 18/(2) |
Previous treatments | |
Surgery | 31 |
Adjuvant treatment | |
CT (DTIC) | 1 |
IT (IF-α) | 12 |
None | 19 |
Treatment for metastatic disease | |
CT (DTIC/CVD) | 4 (4/1) |
IT (IF-α) | 5 |
CT+IT | 8 |
DTIC o CVD+IF-α (±IL-2) | 7 |
DTIC o CVD+IL-2 | 1 |
Hyperthermic isolated limb perfusion | 1 |
None | 14 |
N. lines for metastatic disease | |
0/1/2/>2 | 14/8/6/4 |
Median (range) | 1 (0–5) |
